MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1177/20406207261428774

Медицинская библиотека · Therapeutic advances in hematology · 2026

An analysis of attitudes toward gene therapy in people with severe hemophilia in Germany, a survey-based cross-sectional study.

Babayeva Svetlana, Peyvandi Aida, Schepperle Christian, Auerswald Günter, Rauchfuss Steffen, Peyvandi Flora, Cutica Ilaria, Miesbach Wolfgang

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Severe hemophilia traditionally requires lifelong prophylactic treatment, which cannot fully prevent joint damage and significantly impacts patients' quality of life. In recent years, gene therapy has been extensively researched as a potential cure with a single infusion, but it has not yet gained widespread acceptance.

OBJECTIVES

This study examines the knowledge and attitudes of people with severe hemophilia regarding gene therapy to provide guidance to practitioners in the context of shared decision-making.

DESIGN

Cross-sectional observational study based on a standardized questionnaire.

METHODS

A questionnaire developed by Cutica, Ilaria et al. was evaluated in a self-reported, anonymized survey for a German cohort of 59 people with severe hemophilia. It covered sociodemographic and clinical characteristics, knowledge, attitudes, risk tolerance, and decision-making preferences.

RESULTS

Among 59 people with severe hemophilia A and 10 with severe hemophilia B, 59% expressed a predominantly rejective attitude toward gene therapy. Most had only general knowledge of gene therapy. Concerns about long-term side effects (e.g., cancer development) significantly contribute to a negative attitude toward gene therapy (p = 0.005). People with hemophilia and an annual bleeding rate ⩾1 show a significantly higher willingness to consider or accept gene therapy (p = 0.001). Rejection of gene therapy is significantly associated with high expectations regarding its duration of efficacy and the minimum clotting factor level.

CONCLUSION

Further studies are needed to refine educational concepts for people with hemophilia and clear out misconceptions about gene therapy.

Для цитирования: Babayeva Svetlana, Peyvandi Aida, Schepperle Christian, Auerswald Günter, Rauchfuss Steffen, Peyvandi Flora, Cutica Ilaria, Miesbach Wolfgang. An analysis of attitudes toward gene therapy in people with severe hemophilia in Germany, a survey-based cross-sectional study.. Therapeutic advances in hematology. 2026. DOI: 10.1177/20406207261428774.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.